These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 15488266)
41. An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs. Dewulf J; Laevens H; Koenen F; Vanderhallen H; Mintiens K; Deluyker H; de Kruif A Vaccine; 2000 Oct; 19(4-5):475-82. PubMed ID: 11027811 [TBL] [Abstract][Full Text] [Related]
42. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970 [TBL] [Abstract][Full Text] [Related]
43. The challenges of classical swine fever control: modified live and E2 subunit vaccines. Huang YL; Deng MC; Wang FI; Huang CC; Chang CY Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665 [TBL] [Abstract][Full Text] [Related]
44. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity. Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108 [TBL] [Abstract][Full Text] [Related]
45. Vaccinology of classical swine fever: from lab to field. van Oirschot JT Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784 [TBL] [Abstract][Full Text] [Related]
46. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Koenig P; Lange E; Reimann I; Beer M Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713 [TBL] [Abstract][Full Text] [Related]
47. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals. Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334 [TBL] [Abstract][Full Text] [Related]
48. Factors critical for successful vaccination against classical swine fever in endemic areas. Suradhat S; Damrongwatanapokin S; Thanawongnuwech R Vet Microbiol; 2007 Jan; 119(1):1-9. PubMed ID: 17097243 [TBL] [Abstract][Full Text] [Related]
49. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022 [TBL] [Abstract][Full Text] [Related]
51. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV. Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019 [TBL] [Abstract][Full Text] [Related]
52. Oral immunisation of swine with a classical swine fever vaccine (Chinese strain) and transmission studies in rabbits and sheep. Chenut G; Saintilan AF; Burger C; Rosenthal F; Crucière C; Picard M; Bruyère V; Albina E Vet Microbiol; 1999 Feb; 64(4):265-76. PubMed ID: 10063532 [TBL] [Abstract][Full Text] [Related]
53. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals. Kortekaas J; Vloet RP; Weerdmeester K; Ketelaar J; van Eijk M; Loeffen WL J Virol Methods; 2010 Feb; 163(2):175-85. PubMed ID: 19770004 [TBL] [Abstract][Full Text] [Related]
54. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Moormann RJ; Bouma A; Kramps JA; Terpstra C; De Smit HJ Vet Microbiol; 2000 Apr; 73(2-3):209-19. PubMed ID: 10785329 [TBL] [Abstract][Full Text] [Related]
55. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus. Dong XN; Chen YH Vaccine; 2006 May; 24(19):4029-34. PubMed ID: 16504346 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the protective efficacy of recombinant adenoviruses against classical swine fever. Sun Y; Li HY; Zhang XJ; Chang TM; He F; Wang XP; Liu DF; Qiu HJ Immunol Lett; 2011 Mar; 135(1-2):43-9. PubMed ID: 20923683 [TBL] [Abstract][Full Text] [Related]
57. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif. von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779 [TBL] [Abstract][Full Text] [Related]
58. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination. de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497 [TBL] [Abstract][Full Text] [Related]
59. Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Depner KR; Bouma A; Koenen F; Klinkenberg D; Lange E; de Smit H; Vanderhallen H Vet Microbiol; 2001 Nov; 83(2):107-20. PubMed ID: 11557152 [TBL] [Abstract][Full Text] [Related]
60. Leukocyte subsets and specific antibodies in pigs vaccinated with a classical swine fever subunit (E2) vaccine and the attenuated ORF virus strain D1701. Terzić S; Jemersić L; Lojkić M; Sver L; Valpotić I; Orsolić N; Humski A; Cvetnić Z Acta Vet Hung; 2004; 52(2):151-61. PubMed ID: 15168746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]